LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
9.29
-0.60 (-6.07%)
Feb 21, 2025, 4:00 PM EST - Market closed
LENSAR Employees
LENSAR had 130 employees as of December 31, 2023. The number of employees increased by 20 or 18.18% compared to the previous year.
Employees
130
Change (1Y)
20
Growth (1Y)
18.18%
Revenue / Employee
$375,908
Profits / Employee
-$127,908
Market Cap
107.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 130 | 20 | 18.18% |
Dec 31, 2022 | 110 | 0 | - |
Dec 31, 2021 | 110 | 10 | 10.00% |
Dec 31, 2020 | 100 | 25 | 33.33% |
Dec 31, 2019 | 75 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
LNSR News
- 2 days ago - LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 - GlobeNewsWire
- 17 days ago - Medical Devices Firm Lensar Surges Ahead On Robotic Technology - Seeking Alpha
- 18 days ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day - GlobeNewsWire
- 3 months ago - LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LENSAR Reports Third Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - GlobeNewsWire
- 4 months ago - One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems - GlobeNewsWire